Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/13/2006 | USRE39132 Thiazoline acid derivatives |
06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
06/13/2006 | US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents |
06/13/2006 | US7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
06/13/2006 | CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
06/08/2006 | WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors |
06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
06/08/2006 | WO2006058700A1 Acetamide compounds as fungicides |
06/08/2006 | WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors |
06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
06/08/2006 | US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain |
06/08/2006 | US20060122386 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators |
06/08/2006 | US20060122364 Process for producing dendrimer, building block compound, and process for producing thiophene compound |
06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
06/08/2006 | US20060122222 Heterocycle substituted carboxylic acids |
06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
06/08/2006 | US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
06/08/2006 | CA2558647A1 Insecticidal n-substituted sulfoximines |
06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
06/07/2006 | EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity |
06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
06/07/2006 | EP1666455A1 Amide type carboxamide derivative |
06/07/2006 | EP1666067A1 Drug containing chymase inhibitor as the active ingredient |
06/07/2006 | EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
06/07/2006 | EP1664037A1 Halo substituted benzo [b] thiophenes with pi3k inhibitory activity as therapeutic agents |
06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
06/07/2006 | EP1664025A1 Pyrrol derivatives with antibacterial activity |
06/07/2006 | EP1664023A1 Sustituted isoquinoline derivatives and methods of use |
06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
06/07/2006 | EP1664015A1 Substituted naphthyl benzothiophene acids |
06/07/2006 | EP1664013A1 Calcilytic compounds |
06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
06/07/2006 | EP1664004A1 Method for the production of 4-(4-aminophenyl)-3-morpholinon |
06/07/2006 | EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
06/07/2006 | EP1663976A1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
06/07/2006 | EP1663971A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
06/07/2006 | EP1663959A1 Novel amidine compounds for treating microbial infections |
06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
06/07/2006 | EP1663254A2 Anti-inflamatory phosphonate conjugates |
06/07/2006 | EP1663248A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
06/07/2006 | EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis |
06/07/2006 | EP1448577B1 Rhodium and iridium complexes |
06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
06/07/2006 | CN1784416A 9-ketospinosyn derivatives |
06/07/2006 | CN1784399A 3-carbonylaminothiophenes and their use as fungicides |
06/07/2006 | CN1784393A Chemical compounds |
06/07/2006 | CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems |
06/07/2006 | CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds |
06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
06/06/2006 | US7057054 Hexafluorocyclopentene di-substituted with an alkoxy- and aryl-substituted furan and/or thiophene; e.g., 1,2-bis(2-methoxy-5-phenyl-3-thienyl)hexafluorocyclopentene; nonfading |
06/06/2006 | US7057048 Androgen receptor antagonists |
06/06/2006 | US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
06/06/2006 | US7056940 effective in controlling lepidoptera, coleoptera, mites and other sucking pests |
06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
06/06/2006 | US7056923 Anticoagulants |
06/06/2006 | US7056918 Benzimidazole anti-inflammatory compounds |
06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
06/06/2006 | US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction |
06/06/2006 | US7056348 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair) |
06/06/2006 | CA2213810C Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods |
06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
06/01/2006 | WO2006058012A2 Gonadotropin releasing hormone receptor antagonists |
06/01/2006 | WO2006057961A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
06/01/2006 | WO2006057868A1 Antithrombotic diamides |
06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
06/01/2006 | WO2006036015A3 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
06/01/2006 | WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists |
06/01/2006 | WO2005061467A3 Piperazine derivatives as bradykinin antagonists |
06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
06/01/2006 | US20060116408 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents; methyl 4-(5-chloro-3-methylbenzo[b]thiophene-2-sulfonylamino)-3-methanesulfonylbenzoate |
06/01/2006 | US20060116402 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library |
06/01/2006 | US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |